Colorectal carcinomas with isolated loss of PMS2 staining by immunohistochemistry

25Citations
Citations of this article
28Readers
Mendeley users who have this article in their library.

Abstract

Context.-Isolated loss of PMS2 staining is an uncommon immunophenotype in colorectal carcinomas, accounting for approximately 4% of tumors with microsatellite instability. Limited information regarding these tumors is available in the literature. Objective.-To compare the clinicopathologic features of colorectal carcinomas with isolated PMS2 loss by immunohistochemistry to those with other forms of mismatch repair deficiency. Design.-Ninety-three colorectal carcinomas with isolated PMS2 loss by immunohistochemistry and 193 with other forms of mismatch repair deficiency were identified. Forty (43%) of the isolated PMS2 loss cases and 35 control cases (18%) had a known germline mutation or a clinical diagnosis of Lynch syndrome. Results.-Overall, isolated PMS2-loss tumors occurred in significantly younger patients (P

Cite

CITATION STYLE

APA

Alpert, L., Pai, R. K., Srivastava, A., McKinnon, W., Wilcox, R., Yantiss, R. K., … Frankel, W. L. (2018). Colorectal carcinomas with isolated loss of PMS2 staining by immunohistochemistry. In Archives of Pathology and Laboratory Medicine (Vol. 142, pp. 523–528). College of American Pathologists. https://doi.org/10.5858/arpa.2017-0156-OA

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free